返回
Creative Medical Technology Holdings Inc（CELZ）价格
CELZ 股价走势图
CELZ 收益
Creative Medical Technology Holdings Inc
$1.89
-2.57%
$-0.05
收盘价：Feb 11, 16:00:00 GMT-5
$1.89
0%
$0
盘后：Feb 11, 17:39:03 GMT-5
最新收益结果： Q3 '25
报告： 2025-11-07
历史收益
季度性
年度
EPS
收入
Earnings FAQ
CELZ 最近的每股收益与预期相比如何？
Creative Medical Technology Holdings Inc CELZ 上一季度的收入表现如何？
Creative Medical Technology Holdings Inc 的收入预期是多少？
Creative Medical Technology Holdings Inc 的盈利质量评分是多少？
Creative Medical Technology Holdings Inc 何时发布财报？
Creative Medical Technology Holdings Inc 的预期收益是多少？
Creative Medical Technology Holdings Inc 是否超出收益预期？
关键数据
前收盘价
$1.94
开盘价
$1.85
当日区间
$1.85 - $1.93
52周范围
$1.5 - $6.9
交易量
60.6K
平均成交量
108.8K
每股收益（TTM）
-2.87
股息收益率
--
市值
$4.8M
什么是 CELZ？
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company which focuses on immunology, urology, neurology and orthopedics using adult stem cell treatments and interrelated regenerative technologies for the treatment of multiple indications. The company is headquartered in Phoenix, Arizona and currently employs 4 full-time employees. The company went IPO on 2009-05-01. The firm conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.